Small wonder that on the day the US pharmaceutical company Tanox announced that its new anti-allergy drug, Xolair, had passed Phase II of its clinical trials for peanut allergies, it instantly became the most e-mailed story on Yahoo!
無怪乎美國 Tanox 公司宣布抗過敏新藥「索雷爾」通過花生過敏第 2 期臨床試驗的當天，立即成為 Yahoo！傳閱率最高的「Top1 story」。